As of 6 Sept 2026, Transgene Biotek Ltd share price is ₹2.72. The stock opened at ₹2.72 and had closed at ₹2.77 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹1.83 and a high of ₹4.50. In terms of performance, Transgene Biotek Ltd share price has decreased by 4.23% over the past six months and has decreased by 32.17% over the last year.
Transgene Biotek Stock Price Chart
Transgene Biotek Ltd Overview
About Transgene Biotek
Transgene Biotek is an Indian public biotech firm, established in 1990, focused on R&D for vaccines, oncology, biogenerics, and novel drug delivery (oral/nasal proteins/peptides) for unmet needs, exporting to various global markets and developing treatments for cancer, auto-immune issues, etc
Transgene Biotek Ltd Historical Performance
Transgene Biotek Ltd Fundamentals
Transgene Biotek Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Revenue | 0.36 | 1.04 | 0.41 | 0.24 | 0.30 |
| EBITDA | -0.39 | -0.35 | -0.44 | -0.88 | -0.25 |
| Net Profit | -1.65 | -0.68 | -0.66 | -6.01 | -10.40 |
| EPS | -0.22 | -0.09 | -0.09 | -0.79 | -1.37 |
Transgene Biotek Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 2.63 |
| Resistance 1 (R1) | 2.93 |
| Pivot Point | 2.79 |
Transgene Biotek Ltd Corporate Actions
| Corporate Action | Ex Date | Record Date |
|---|---|---|
| No forthcoming board meetings available. | ||
Transgene Biotek Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Apollo Hospitals Enterprise LtdAPOLLOHOSP | ₹8,650.00-0.48% | ₹1,10,231.07 | 59.08 | 20.48% |
| Max Healthcare Institute LtdMAXHEALTH | ₹984.80-1.02% | ₹1,02,534.79 | 72.27 | 13.42% |
| Fortis Healthcare LtdFORTIS | ₹905.00-1.36% | ₹68,746.49 | 70.10 | 10.53% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Transgene Biotek Ltd today is ₹2.72 on NSE and ₹2.72 on BSE.
- The 52-week high of Transgene Biotek Ltd is ₹4.50, while the 52-week low is ₹1.83.
- The current market capitalisation of Transgene Biotek Ltd is approximately ₹21 crore.
- The P/E (Price-to-Earnings) ratio of Transgene Biotek Ltd is -9.60. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Transgene Biotek Ltd is 1.97. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Transgene Biotek Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for Transgene Biotek on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Transgene Biotek Ltd has delivered a return of approximately -38.04%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Transgene Biotek Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 23.64% promoters, 0.00% FIIs, 0.00% DIIs, and 71.70% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
